Brain cell atlas for Alzheimer's disease is the target of NIH's new collaboration with 10x Genomics
Building on recent efforts to create detailed molecular maps of the human brain, the National Institutes of Health has tapped 10x Genomics for help building atlases that compare the brains of healthy people to those with neurodegenerative conditions including Alzheimer’s disease, the company told Endpoints News in an exclusive interview.
The California biotech is one of the leaders in technologies that crack open individual cells to measure which genes are turned on and off. By doing so, scientists hope to glean new insights about what keeps some cells healthy and what makes other cells sick.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.